WHO ICTRP trial
A multi-center, open clinical trial to evaluate the effectiveness and safety of…
ChiCTR2000039510 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2000039510 |
|---|---|
| Public title | A multi-center, open clinical trial to evaluate the effectiveness and safety of perampanel as an early add-on treatment for partial seizure |
| Scientific title | A multi-center, open clinical trial to evaluate the effectiveness and safety of perampanel as an early add-on treatment for partial seizure |
| Primary sponsor | Xuanwu Hospital of Capital Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Epilepsy |
| Interventions | experimental group:Perampanel tablets |
| Registration date | Oct 30, 2020 |
| Target size | experimental group:300 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: